AIM
AIM ImmunoTech
36 hedge funds and large institutions have $14.7M invested in AIM ImmunoTech in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$468K | |
| 2 | +$110K | |
| 3 | +$81.8K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
+$56K |
Top Sellers
| 1 | -$329K | |
| 2 | -$248K | |
| 3 | -$63K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$52.1K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$44K |